UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Systematic review and meta-analysis of randomized trials of central nervous system directed therapy for childhood acute lymphoblastic leukemia

Pediatric blood & cancer, 2013-02, Vol.60 (2), p.185-195

2013

Volltextzugriff (PDF)

Beneficial and harmful effects of anthracyclines in the treatment of childhood acute lymphoblastic leukaemia: a systematic review and meta‐analysis

British journal of haematology, 2009-05, Vol.145 (3), p.376-388

Childhood Acute Lymphoblastic Leukaemia Collaborative Group (CALLCG),

2009

Volltextzugriff (PDF)

Myeloablative chemotherapy with autologous bone marrow rescue in children and adolescents with recurrent malignant astrocytoma: Outcome compared with conventional chemotherapy: A report from the Children's Oncology Group

Pediatric Blood & Cancer, 2008-12, Vol.51 (6), p.806-811

2008

Volltextzugriff (PDF)

Phase II trial of clofarabine with topotecan, vinorelbine, and thiotepa in pediatric patients with relapsed or refractory acute leukemia

Pediatric blood & cancer, 2014-03, Vol.61 (3), p.431-435

2014

Volltextzugriff (PDF)

Vincristine toxicity with co‐administration of fluconazole: Long‐term concerns

Pediatric blood & cancer, 2017-12, Vol.64 (12), p.n/a

2017

Volltextzugriff (PDF)

Treatment of higher risk acute lymphoblastic leukemia in young people (CCG-1961), long-term follow-up: a report from the Children’s Oncology Group

Leukemia, 2019-09, Vol.33 (9), p.2144-2154

2019

Volltextzugriff (PDF)

Phase 2 trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute lymphoblastic leukemia

Blood, 2011-12, Vol.118 (23), p.6043-6049

2011

Volltextzugriff (PDF)

Intensified Chemotherapy With Dexrazoxane Cardioprotection in Newly Diagnosed Nonmetastatic Osteosarcoma: A Report From the Children's Oncology Group

Pediatric blood & cancer, 2016-01, Vol.63 (1), p.54-61

2016

Volltextzugriff (PDF)

Impact of Bridging Chemotherapy on Clinical Outcomes of CD19-Specific CAR T Cell Therapy in Children/Young Adults with Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia

Transplantation and cellular therapy, 2022-02, Vol.28 (2), p.72.e1-72.e8

2022

Volltextzugriff (PDF)

Trametinib-induced Left Ventricular Dysfunction in a Child With Relapsed Neuroblastoma

Journal of pediatric hematology/oncology, 2015-08, Vol.37 (6), p.e381-e383

2015

Volltextzugriff (PDF)

Remission re-induction chemotherapy with clofarabine, topotecan, thiotepa, and vinorelbine for patients with relapsed or refractory leukemia

Pediatric blood & cancer, 2010-05, Vol.54 (5), p.687-693

2010

Volltextzugriff (PDF)

Maintenance chemotherapy to reduce the risk of a metachronous Wilms tumor in children with bilateral nephroblastomatosis

Pediatric blood & cancer, 2019-01, Vol.66 (1), p.e27500-n/a

2019

Volltextzugriff (PDF)

Hypodiploidy With Less Than 45 Chromosomes Confers Adverse Risk in Childhood Acute Lymphoblastic Leukemia: A Report From the Children's Cancer Group

Blood, 1999-12, Vol.94 (12), p.4036-4045

1999

Volltextzugriff (PDF)

Outcome of children and adolescents with relapsed Hodgkin lymphoma treated with high-dose therapy and autologous stem cell transplantation: the Memorial Sloan Kettering Cancer Center experience

Leukemia & lymphoma, 2018-08, Vol.59 (8), p.1861-1870

2018

Volltextzugriff (PDF)

Clofarabine with topotecan, vinorelbine, and thiotepa reinduction regimen for children and young adults with relapsed AML

Blood advances, 2022-04, Vol.6 (8), p.2688-2694

2022

Volltextzugriff (PDF)

A multi-center phase I study of clofarabine, etoposide and cyclophosphamide in combination in pediatric patients with refractory or relapsed acute leukemia

Leukemia, 2009-12, Vol.23 (12), p.2259-2264

2009

Volltextzugriff (PDF)

Deletion of 7p or monosomy 7 in pediatric acute lymphoblastic leukemia is an adverse prognostic factor: a report from the Children's Cancer Group

Leukemia, 2004-05, Vol.18 (5), p.939-947

2004

Volltextzugriff (PDF)

Ten-year follow-up of pediatric patients with non-hodgkin lymphoma treated with allogeneic or autologous stem cell transplantation

Pediatric blood & cancer, 2013-12, Vol.60 (12), p.2018-2024

2013

Volltextzugriff (PDF)

A new multidrug reinduction protocol with topotecan, vinorelbine, thiotepa, dexamethasone, and gemcitabine for relapsed or refractory acute leukemia

Leukemia, 2003-10, Vol.17 (10), p.1967-1972

2003

Volltextzugriff (PDF)

High-dose cyclophosphamide for the treatment of refractory T-cell acute lymphoblastic leukemia in children

Journal of pediatric hematology/oncology, 2014-07, Vol.36 (5), p.e265-e270

2014

Volltextzugriff (PDF)

Myelodysplastic and Myeloproliferative Disorders of Childhood: A Study of 167 Patients

Blood, 1999-01, Vol.93 (2), p.459-466

1999

Volltextzugriff (PDF)

Biology and Treatment of Childhood T-Lineage Acute Lymphoblastic Leukemia

Blood, 1998-02, Vol.91 (3), p.735-746

1998

Volltextzugriff (PDF)

Clofarabine induced durable complete remission in heavily pretreated adolescents with relapsed and refractory leukemia

Journal of pediatric hematology/oncology, 2007-09, Vol.29 (9), p.656-658

2007

Volltextzugriff (PDF)

1 – 25 von 70

Suche als RSS-Feed

Aktive Filter

ThemaHematology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(63)
Mit Volltextzugriff
(52)

Publikationsform

Artikel
(70)

Sprache

Englisch
(70)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(70)
Science & Technology
(70)
Humans
(65)
Child
(55)
Male
(47)
Child, Preschool
(43)
Female
(39)
Oncology
(39)
Adolescent
(37)
Infant
(36)
Biological And Medical Sciences
(31)
Medical Sciences
(31)
Pediatrics
(24)
Adult
(23)
Precursor Cell Lymphoblastic Leukemia-Lymphoma - Drug Therapy
(23)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(22)
Hematologic And Hematopoietic Diseases
(21)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(21)
Prognosis
(20)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Systematic review and meta-analysis of randomized trials of central nervous system directed therapy for childhood acute lymphoblastic leukemia

Beneficial and harmful effects of anthracyclines in the treatment of childhood acute lymphoblastic leukaemia: a systematic review and meta‐analysis

Myeloablative chemotherapy with autologous bone marrow rescue in children and adolescents with recurrent malignant astrocytoma: Outcome compared with conventional chemotherapy: A report from the Children's Oncology Group

Phase II trial of clofarabine with topotecan, vinorelbine, and thiotepa in pediatric patients with relapsed or refractory acute leukemia

Vincristine toxicity with co‐administration of fluconazole: Long‐term concerns

Treatment of higher risk acute lymphoblastic leukemia in young people (CCG-1961), long-term follow-up: a report from the Children’s Oncology Group

Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL

Phase 2 trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute lymphoblastic leukemia

Intensified Chemotherapy With Dexrazoxane Cardioprotection in Newly Diagnosed Nonmetastatic Osteosarcoma: A Report From the Children's Oncology Group

Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group

Impact of Bridging Chemotherapy on Clinical Outcomes of CD19-Specific CAR T Cell Therapy in Children/Young Adults with Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia

Trametinib-induced Left Ventricular Dysfunction in a Child With Relapsed Neuroblastoma

Remission re-induction chemotherapy with clofarabine, topotecan, thiotepa, and vinorelbine for patients with relapsed or refractory leukemia

Maintenance chemotherapy to reduce the risk of a metachronous Wilms tumor in children with bilateral nephroblastomatosis

Hypodiploidy With Less Than 45 Chromosomes Confers Adverse Risk in Childhood Acute Lymphoblastic Leukemia: A Report From the Children's Cancer Group

Outcome of children and adolescents with relapsed Hodgkin lymphoma treated with high-dose therapy and autologous stem cell transplantation: the Memorial Sloan Kettering Cancer Center experience

Clofarabine with topotecan, vinorelbine, and thiotepa reinduction regimen for children and young adults with relapsed AML

A multi-center phase I study of clofarabine, etoposide and cyclophosphamide in combination in pediatric patients with refractory or relapsed acute leukemia

Deletion of 7p or monosomy 7 in pediatric acute lymphoblastic leukemia is an adverse prognostic factor: a report from the Children's Cancer Group

Ten-year follow-up of pediatric patients with non-hodgkin lymphoma treated with allogeneic or autologous stem cell transplantation

A new multidrug reinduction protocol with topotecan, vinorelbine, thiotepa, dexamethasone, and gemcitabine for relapsed or refractory acute leukemia

High-dose cyclophosphamide for the treatment of refractory T-cell acute lymphoblastic leukemia in children

Myelodysplastic and Myeloproliferative Disorders of Childhood: A Study of 167 Patients

Biology and Treatment of Childhood T-Lineage Acute Lymphoblastic Leukemia

Clofarabine induced durable complete remission in heavily pretreated adolescents with relapsed and refractory leukemia

Aktive Filter

Suchergebnisse filtern